Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Safety and Immunogenicity Of A Recombinant H5N1 Vaccine In Adults

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Fraunhofer, Center for Molecular Biotechnology
ClinicalTrials.gov Identifier:
NCT01250795
First received: November 29, 2010
Last updated: May 10, 2016
Last verified: May 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2011
  Primary Completion Date: July 2011 (Final data collection date for primary outcome measure)